Coronavirus: Covid-19 vaccine from Pfizer and BioNTech ‘90 per cent effective in preventing the disease’

A PHARMACEUTICAL giant has announced that its coronavirus vaccine was more than 90 per cent effective in preventing the virus among those without evidence of prior infection.
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

US company Pfizer has been working on a Covid-19 vaccination with biotech firm BioNTech.

The results are based on the first interim analysis of Phase 3 of the study, and evaluated 94 confirmed cases of Covid-19 in trial participants.

Hide Ad
Hide Ad

The study enrolled 43,538 participants, with 42 per cent having diverse backgrounds, and no serious safety concerns have been observed, the companies report.

This is what coronavirus looks like. Picture: ShutterstockThis is what coronavirus looks like. Picture: Shutterstock
This is what coronavirus looks like. Picture: Shutterstock
Read More
Plea from defiant Portsmouth traders asking customers to ditch Amazon and follow...

They add that safety and additional efficacy data continue to be collected.

The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90 per cent, at seven days after the second dose.

Researchers say this means that protection is achieved 28 days after the initiation of the vaccination, which consists of two doses.

Hide Ad
Hide Ad

However, they caution that as the study continues the final vaccine efficacy percentage may vary.

Dr Albert Bourla, Pfizer chairman and chief executive, said: ‘Today is a great day for science and humanity.

‘The first set of results from our Phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19.’

He added: ‘We will continue to collect further data as the trial continues to enrol for a final analysis planned when a total of 164 confirmed Covid-19 cases have accrued.

Hide Ad
Hide Ad

‘I would like to thank everyone who has contributed to make this important achievement possible.’

On Twitter, The Times Whitehall Editor Chris Smyth tweeted: ‘UK has agreement to buy 40 million doses of Pfizer vaccine – including 10 million due by the end of the year if it is approved by regulators.’

A message from the Editor, Mark Waldron

The News is more reliant than ever on you taking out a digital subscription to support our journalism.

You can subscribe here for unlimited access to Portsmouth news online - as well as our new Puzzles section.

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.